Odin Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Odin Technologies is targeting a critical unmet need in trauma and critical care with its non-invasive Hemoflow monitor. The company's platform combines a wearable sensor with proprietary deep learning algorithms to provide continuous, real-time data on limb perfusion, potentially preventing unnecessary invasive surgeries. Founded in 2020, the startup has garnered early recognition through pitch competitions and accelerator programs and is building a team with expertise in clinical medicine, AI, and medical device operations. Its initial focus is on improving the diagnostic pathway for Acute Compartment Syndrome.

TraumaCritical CareOrthopedics

Technology Platform

Non-invasive wearable sensor using light emitters/detectors combined with a proprietary deep learning AI algorithm for real-time hemodynamic monitoring and diagnostics.

Opportunities

The primary opportunity is to replace the invasive and unreliable current standard of care for ACS diagnosis, potentially preventing a large majority of unnecessary emergency surgeries.

Success in this niche could open the larger market for continuous, non-invasive perfusion monitoring in hospital and post-surgical settings.

Risk Factors

Key risks include the need to clinically validate that the AI-driven optical sensor is as accurate as (or better than) invasive pressure monitoring for diagnosing ACS.

The company also faces regulatory hurdles for a novel diagnostic device and the challenge of changing established clinical practices in a high-stakes field.

Competitive Landscape

The competitive landscape for non-invasive ACS monitoring is emerging but not yet crowded with established solutions. Odin competes against the entrenched, albeit disliked, standard of invasive pressure monitors. Potential competitors include other startups developing optical or bioimpedance-based monitors and large medtech companies with interests in patient monitoring who could develop or acquire similar technology.

More companies in Digital Health & Biotech SaaS →More companies in United States →